Charles Boy Kromann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Charles Boy Kromann has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Gregor Borut Ernst Jemec
Department of Dermatology and Allergy, PHOENIX Research Center Copenhagen University Hospital ‐ Herlev and Gentofte Gentofte Denmark
7 shared publications Charlotte Ringsted
Department of Anesthesia and The Wilson Centre, 200 Elizabeth Street, 1ES-565, Toronto, Ontario, Canada M5G 2C4
4 shared publicationsDanni Hvidtfeldt
Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark
2 shared publications- Kristina Sophie Ibler
Department of Dermatology Zealand University Hospital, University of Copenhagen Roskilde Denmark
2 shared publications Mette Koefoed
Department of Dermato-Venerology, Health Sciences Faculty, Roskilde Hospital, University of Copenhagen, Copenhagen, Denmark and
2 shared publications- Mette Koefoed
Department of Internal Medicine, Section of Nephrology, Holbæk Hospital, Denmark
2 shared publications
Latest Publications
- 9 September 2019
- Published by Wiley in International Journal of Dermatology
- Vol. 59 (1) , 47-51
Hidradenitis suppurativa in a cohort of overweight and obese children and adolescents
Background: Hidradenitis suppurativa (HS) is a chronic, inflammatory, and recurring disease mainly observed in adults. Obesity is considered an important independent factor in HS development and is associated with a higher prevalence of HS in children. We aimed to characterize the clinical presentation of HS in overweight and obese children and adolescents.Methods: We performed a cross‐sectional observational study during January 2007–April 2015. Overweight and obese patients (5–17 years of age, BMI> 90th percentile) referred to The Children’s Obesity Clinic, Department of Paediatrics, Copenhagen University Hospital Holbæk, Denmark, underwent screening for dermatological conditions. A dermatologist ascertained the diagnosis of HS, and disease severity was assessed using Hurley staging and Sartorius score. Tobacco smoke exposure, body mass index (BMI) standard deviation score (SDS), and psychiatric comorbidities were recorded. Our cohort was compared with a reference cohort recruited in a previous study.Results: A total of 195 children and adolescents underwent screening for dermatological conditions. Nine patients screened positive, and six of these patients were available for examination of whom five presented with HS. All HS cases were mild (median Sartorius score of 9). Four of the five patients (with varying constellations) reported tobacco exposure, a positive family history of HS, and exhibited psychiatric comorbidities.Conclusion: Our findings support that the presence of pediatric HS is correlated with familial disposition to HS and psychiatric comorbidities.
- 9 September 2019
- Published by Wiley in International Journal of Dermatology
- Vol. 59 (1) , 47-51
Hidradenitis suppurativa in a cohort of overweight and obese children and adolescents
Background: Hidradenitis suppurativa (HS) is a chronic, inflammatory, and recurring disease mainly observed in adults. Obesity is considered an important independent factor in HS development and is associated with a higher prevalence of HS in children. We aimed to characterize the clinical presentation of HS in overweight and obese children and adolescents.Methods: We performed a cross‐sectional observational study during January 2007–April 2015. Overweight and obese patients (5–17 years of age, BMI> 90th percentile) referred to The Children’s Obesity Clinic, Department of Paediatrics, Copenhagen University Hospital Holbæk, Denmark, underwent screening for dermatological conditions. A dermatologist ascertained the diagnosis of HS, and disease severity was assessed using Hurley staging and Sartorius score. Tobacco smoke exposure, body mass index (BMI) standard deviation score (SDS), and psychiatric comorbidities were recorded. Our cohort was compared with a reference cohort recruited in a previous study.Results: A total of 195 children and adolescents underwent screening for dermatological conditions. Nine patients screened positive, and six of these patients were available for examination of whom five presented with HS. All HS cases were mild (median Sartorius score of 9). Four of the five patients (with varying constellations) reported tobacco exposure, a positive family history of HS, and exhibited psychiatric comorbidities.Conclusion: Our findings support that the presence of pediatric HS is correlated with familial disposition to HS and psychiatric comorbidities.
- 1 September 2016
- Published by Elsevier in Journal of Renal Nutrition
- Vol. 26 (5) , 320-324
Historical Study (1986-2014): Improvements in Nutritional Status of Dialysis Patients
- 1 September 2016
- Published by Elsevier in Journal of Renal Nutrition
- Vol. 26 (5) , 320-324
Historical Study (1986-2014): Improvements in Nutritional Status of Dialysis Patients
- Open Access
- 26 February 2016
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (2) , e0150012
Nutritional Status of Maintenance Dialysis Patients: Low Lean Body Mass Index and Obesity Are Common, Protein-Energy Wasting Is Uncommon
Maintenance dialysis patients are at increased risk of abnormal nutritional status due to numerous causative factors, both nutritional and non-nutritional. The present study assessed the current prevalence of protein-energy wasting, low lean body mass index and obesity in maintenance dialysis patients, and compared different methods of nutritional assessment. In a cross-sectional study conducted in 2014 at Roskilde Hospital, Denmark, we performed anthropometry (body weight, skinfolds, mid-arm, waist, and hip circumferences), and determined plasma albumin and normalized protein catabolic rate in order to assess the prevalence of protein-energy wasting, low lean body mass index and obesity in these patients. Seventy-nine eligible maintenance dialysis patients participated. The prevalence of protein-energy wasted patients was 4% (95% CI: 2–12) as assessed by the coexistence of low lean body mass index and low fat mass index. Low lean body mass index was seen in 32% (95% CI: 22–44). Obesity prevalence as assessed from fat mass index was 43% (95% CI: 32–55). Coexistence of low lean body mass index and obesity was seen in 10% (95% CI: 5–19). The prevalence of protein-energy wasting and obesity varied considerably, depending on nutritional assessment methodology. Our data indicate that protein-energy wasting is uncommon, whereas low lean body mass index and obesity are frequent conditions among patients in maintenance dialysis. A focus on how to increase and preserve lean body mass in dialysis patients is suggested in the future. In order to clearly distinguish between shortage, sufficiency and abundance of protein and/or fat deposits in maintenance dialysis patients, we suggest the simple measurements of lean body mass index and fat mass index.
- 26 February 2016
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (2) , e0150012
Open AccessNutritional Status of Maintenance Dialysis Patients: Low Lean Body Mass Index and Obesity Are Common, Protein-Energy Wasting Is Uncommon
Maintenance dialysis patients are at increased risk of abnormal nutritional status due to numerous causative factors, both nutritional and non-nutritional. The present study assessed the current prevalence of protein-energy wasting, low lean body mass index and obesity in maintenance dialysis patients, and compared different methods of nutritional assessment. In a cross-sectional study conducted in 2014 at Roskilde Hospital, Denmark, we performed anthropometry (body weight, skinfolds, mid-arm, waist, and hip circumferences), and determined plasma albumin and normalized protein catabolic rate in order to assess the prevalence of protein-energy wasting, low lean body mass index and obesity in these patients. Seventy-nine eligible maintenance dialysis patients participated. The prevalence of protein-energy wasted patients was 4% (95% CI: 2–12) as assessed by the coexistence of low lean body mass index and low fat mass index. Low lean body mass index was seen in 32% (95% CI: 22–44). Obesity prevalence as assessed from fat mass index was 43% (95% CI: 32–55). Coexistence of low lean body mass index and obesity was seen in 10% (95% CI: 5–19). The prevalence of protein-energy wasting and obesity varied considerably, depending on nutritional assessment methodology. Our data indicate that protein-energy wasting is uncommon, whereas low lean body mass index and obesity are frequent conditions among patients in maintenance dialysis. A focus on how to increase and preserve lean body mass in dialysis patients is suggested in the future. In order to clearly distinguish between shortage, sufficiency and abundance of protein and/or fat deposits in maintenance dialysis patients, we suggest the simple measurements of lean body mass index and fat mass index.
- 10 August 2015
- Vol. 177 (33) , V06140322
[Renal angiomyolipoma with spontaneous retroperitoneal bleeding].
Angiomyolipoma (AML) is a benign tumour composed predominantly of blood vessels, smooth muscle tissue and adipose tissue. It is a rare disorder found in 0.1% of men and 0.22% of women. AML is most often manifested as a solitary tumour, but can also be found with multiple lesions in various organs. AML is predominantly asymptomatic, but may present with different symptoms depending on the size and position. Patients often have flank pain and microscopic or macroscopic haematuria. AML can also debut with spontaneous atraumatic bleeding in the retroperitoneum, Wunderlich's syndrome.
- 10 August 2015
- Vol. 177 (33) , V06140322
[Renal angiomyolipoma with spontaneous retroperitoneal bleeding].
Angiomyolipoma (AML) is a benign tumour composed predominantly of blood vessels, smooth muscle tissue and adipose tissue. It is a rare disorder found in 0.1% of men and 0.22% of women. AML is most often manifested as a solitary tumour, but can also be found with multiple lesions in various organs. AML is predominantly asymptomatic, but may present with different symptoms depending on the size and position. Patients often have flank pain and microscopic or macroscopic haematuria. AML can also debut with spontaneous atraumatic bleeding in the retroperitoneum, Wunderlich's syndrome.
- Open Access
- 1 January 2015
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 95 (1) , 121-123
Recurring Axillary, Abdominal and Genitofemoral Nodules and Abscesses: A Quiz
- 1 January 2015
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 95 (1) , 121-123
Open AccessRecurring Axillary, Abdominal and Genitofemoral Nodules and Abscesses: A Quiz
- 1 January 2015
- Published by Springer Nature
- p. 1-6
High-Frequency Ultrasound of the Nail
- Open Access
- 1 September 2014
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 94 (5) , 553-557
The Influence of Body Weight on the Prevalence and Severity of Hidradenitis Suppurativa
The prevalence of hidradenitis suppurativa (HS) has been estimated to be 1% of the population. Obesity is considered a co-morbidity, but the...
- 1 September 2014
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 94 (5) , 553-557
Open AccessThe Influence of Body Weight on the Prevalence and Severity of Hidradenitis Suppurativa
The prevalence of hidradenitis suppurativa (HS) has been estimated to be 1% of the population. Obesity is considered a co-morbidity, but the...
- 17 June 2014
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 26 (2) , 188-190
Does switching from oral to subcutaneous administration of methotrexate influence on patient reported gastro-intestinal adverse effects?
When treating patients with methotrexate (MTX) the most frequently reported adverse effects (AE) are gastrointestinal (GI) with nausea being reported by 10-20%. If intolerable AE of oral MTX persist, switching from oral to subcutaneous (SC) or intramuscular (IM) administration is common. However, this approach is largely empirical and the evidence is inconsistent. To our knowledge, this will be the first study to estimate the change in GI AE of switching from oral to SC MTX. A retrospective postal survey was sent to patients who had changed from oral MTX to SC MTX. GI AE was rated by visual analogue scale (VAS) regarding frequency and intensity of nausea, frequency of vomiting and frequency of discomfort. All participants gave informed consent. No further ethical clearance was necessary according to national law. Of the sample 39/57 (68.4%) responded. Significant reductions in VAS were found in three of four primary outcome measures for GI AE. Only frequency of vomiting was not significantly reduced. Our findings support the common practice of switching from oral to SC MTX to alleviate GI AE, however, additional research is needed in order to clarify this rarely studied subject.
- 17 June 2014
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 26 (2) , 188-190
Does switching from oral to subcutaneous administration of methotrexate influence on patient reported gastro-intestinal adverse effects?
When treating patients with methotrexate (MTX) the most frequently reported adverse effects (AE) are gastrointestinal (GI) with nausea being reported by 10-20%. If intolerable AE of oral MTX persist, switching from oral to subcutaneous (SC) or intramuscular (IM) administration is common. However, this approach is largely empirical and the evidence is inconsistent. To our knowledge, this will be the first study to estimate the change in GI AE of switching from oral to SC MTX. A retrospective postal survey was sent to patients who had changed from oral MTX to SC MTX. GI AE was rated by visual analogue scale (VAS) regarding frequency and intensity of nausea, frequency of vomiting and frequency of discomfort. All participants gave informed consent. No further ethical clearance was necessary according to national law. Of the sample 39/57 (68.4%) responded. Significant reductions in VAS were found in three of four primary outcome measures for GI AE. Only frequency of vomiting was not significantly reduced. Our findings support the common practice of switching from oral to SC MTX to alleviate GI AE, however, additional research is needed in order to clarify this rarely studied subject.
- 7 May 2014
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 171 (4) , 819-824
Risk factors, clinical course and long‐term prognosis in hidradenitis suppurativa: a cross‐sectional study
Background Hidradenitis suppurativa (HS) causes considerable morbidity. The long‐term prognosis is of obvious interest to both patients and physicians. We conducted this study to determine the prognosis and risk factors in patients diagnosed with HS. Objectives To describe the long‐term prognosis and the clinical course of HS and its association to known risk factors. Methods A postal follow‐up survey with uncomplicated factual questions was conducted. As all of the patients were well acquainted with their long‐standing disease, this was thought to be sufficient for meaningful results. All cases were diagnosed by a dermatologist. Overall, 212 patients diagnosed with HS between 1981 and 2001 were studied after a median follow‐up period of 22 years (range 12–32). Results The overall response rate was 71·2%, with 60·8% (129/212) valid (fully completed) questionnaires. Remission was reported by 39·4% (50/127) and improvement by 31·5% (40/127). Unchanged severity was reported by 20·5% (26/127), and 8·7% (11/127) experienced worsening disease. Tobacco smoking was reported by 92·2% (119/129). Among nonsmokers, 40% (35/88) reported remission vs. 29% (17/59) of active smokers. A higher proportion of nonobese patients (45%) reported remission than obese patients (23%). Conclusions We found that 39·4% of the sample reported remission of HS. Suspected risk factors appeared to influence the prognosis. Smoking and obesity were significantly linked to a lower rate of self‐reported remission. The notion that lifestyle factors play a role in HS appears to be supported by this survey.
- 7 May 2014
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 171 (4) , 819-824
Risk factors, clinical course and long‐term prognosis in hidradenitis suppurativa: a cross‐sectional study
Background Hidradenitis suppurativa (HS) causes considerable morbidity. The long‐term prognosis is of obvious interest to both patients and physicians. We conducted this study to determine the prognosis and risk factors in patients diagnosed with HS. Objectives To describe the long‐term prognosis and the clinical course of HS and its association to known risk factors. Methods A postal follow‐up survey with uncomplicated factual questions was conducted. As all of the patients were well acquainted with their long‐standing disease, this was thought to be sufficient for meaningful results. All cases were diagnosed by a dermatologist. Overall, 212 patients diagnosed with HS between 1981 and 2001 were studied after a median follow‐up period of 22 years (range 12–32). Results The overall response rate was 71·2%, with 60·8% (129/212) valid (fully completed) questionnaires. Remission was reported by 39·4% (50/127) and improvement by 31·5% (40/127). Unchanged severity was reported by 20·5% (26/127), and 8·7% (11/127) experienced worsening disease. Tobacco smoking was reported by 92·2% (119/129). Among nonsmokers, 40% (35/88) reported remission vs. 29% (17/59) of active smokers. A higher proportion of nonobese patients (45%) reported remission than obese patients (23%). Conclusions We found that 39·4% of the sample reported remission of HS. Suspected risk factors appeared to influence the prognosis. Smoking and obesity were significantly linked to a lower rate of self‐reported remission. The notion that lifestyle factors play a role in HS appears to be supported by this survey.